The Precision Peptide Genetic Test reveals predispositions in key GLP-1 pathway variantsincluding GIPR rs1800437that relate to how your body's GLP-1 signaling responds to consistent drug dosing and timing
Taken together, weight loss induced bone loss represents a clinical challenge that is likely to be more prevalent as anti-obesity treatments become more widely available
If you want a deeper dive to discuss your specific medical background (do you have a history of breast cancer
This dual-action approach not only enhances the bodys ability to manage glucose levels but also promotes a feeling of fullness, making it easier for individuals to adhere to dietary changes
These effects contribute to its potential in mitigating key mechanisms underlying cardiovascular diseases (CVDs), such as oxidative stress, endothelial dysfunction, and inflammation
If you relate to any of the following, you may be a candidate for GLP-1 Agonist: BMI over 27 (or over 25 with an obesity-related condition like diabetes or high blood pressure) Previous difficulty losing and keeping weight off with diet, exercise, and/or other medications Ready for an extra push to boost your weight loss results Wanting to improve your health by losing excess body weight Our medical providers will thoroughly assess your health profile during a consultation to determine if GLP-1 Agonist is appropriate for your needs and goals